RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $550,490 | -21.1% | 84,431 | +0.5% | 0.00% | 0.0% |
| Q1 2024 | $697,308 | -26.0% | 84,013 | -1.8% | 0.00% | 0.0% |
| Q4 2023 | $941,740 | +24.7% | 85,535 | -4.7% | 0.00% | 0.0% |
| Q3 2023 | $754,907 | -39.6% | 89,763 | -9.7% | 0.00% | -50.0% |
| Q2 2023 | $1,249,029 | -24.7% | 99,445 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,658,562 | +8.9% | 100,702 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $1,523,492 | -30.1% | 101,974 | +4.8% | 0.00% | -50.0% |
| Q3 2022 | $2,178,000 | +47.7% | 97,342 | +10.6% | 0.00% | +100.0% |
| Q2 2022 | $1,475,000 | -26.2% | 88,031 | +31.9% | 0.00% | -33.3% |
| Q1 2022 | $1,998,000 | -12.0% | 66,758 | -9.7% | 0.00% | 0.0% |
| Q4 2021 | $2,270,000 | +22.4% | 73,904 | +25.6% | 0.00% | +50.0% |
| Q3 2021 | $1,855,000 | -37.2% | 58,843 | -27.1% | 0.00% | -50.0% |
| Q2 2021 | $2,953,000 | +23.5% | 80,693 | +16.7% | 0.00% | +33.3% |
| Q1 2021 | $2,391,000 | +18.1% | 69,165 | +42.0% | 0.00% | 0.0% |
| Q4 2020 | $2,024,000 | -2.4% | 48,708 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,074,000 | – | 48,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |